Ovid Therapeutics Inc.·4

Apr 3, 4:43 PM ET

Rakhit Amit 4

4 · Ovid Therapeutics Inc. · Filed Apr 3, 2019

Insider Transaction Report

Form 4
Period: 2019-04-01
Rakhit Amit
CMO and PMO
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2019-04-01+50,00050,000 total
    Exercise: $1.76Exp: 2029-03-31Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the Stock Option will vest and become exercisable on April 1, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION